Cargando…

Wound complications frequency in heart transplant recipients on mammalian target of rapamycin inhibitors: A meta‐analysis

A meta‐analysis investigation was executed to measurethe wound complications (WCs) frequency in heart transplant (HT) recipients on mammalian target of rapamycin inhibitors (MTRIs). A comprehensive literature investigation till February 2023 was applied and 978 interrelated investigations were revie...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zhu, Shenyu, Yu, Wenbo, Gao, Jianfeng, Xiong, Jianxian
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Blackwell Publishing Ltd 2023
Materias:	Original Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10588318/ https://www.ncbi.nlm.nih.gov/pubmed/37165731 http://dx.doi.org/10.1111/iwj.14221

Ejemplares similares

Platelet‐rich plasma influence on the sternal wounds healing: A meta‐analysis
por: Zhu, Shenyu, et al.
Publicado: (2023)

Mammalian Target of Rapamycin Inhibitors and Wound Healing Complications in Kidney Transplantation: Old Myths and New Realities
por: Mabood Khalil, Muhammad Abdul, et al.
Publicado: (2022)

Conversion to mammalian target of rapamycin inhibitors in kidney transplant recipients with de novo cancers
por: Cheung, Chi Yuen, et al.
Publicado: (2017)

Effect of Calcineurin Inhibitors and Mammalian Target of Rapamycin Inhibitors on the Course of COVID-19 in Kidney Transplant Recipients
por: Hasbal, Nuri Baris, et al.
Publicado: (2021)

Conversion From Calcineurin Inhibitors to Mammalian Target of Rapamycin Inhibitors in Kidney Transplant Recipients: A Systematic Review and Meta-Analysis of Randomized Controlled Trials
por: Zeng, Jun, et al.
Publicado: (2021)

Pathology of Calcineurin and Mammalian Target of Rapamycin Inhibitors in Kidney Transplantation
por: Leal, Rita, et al.
Publicado: (2017)

Mammalian Target of Rapamycin Inhibitors and Kidney Function After Thoracic Transplantation: A Systematic Review and Recommendations for Management of Lung Transplant Recipients
por: Schmucki, Katja, et al.
Publicado: (2022)

Renal function in heart transplant patients after switch to combined mammalian target of rapamycin inhibitor and calcineurin inhibitor therapy
por: Helmschrott, Matthias, et al.
Publicado: (2017)

Systemic meta-analysis assessing the short term applicability of early conversion to mammalian target of rapamycin inhibitors in kidney transplant
por: Kumar, Jayant, et al.
Publicado: (2017)

Case report: Surgery combined with extracorporeal membrane oxygenation for a patient with type A aortic dissection complicated with myocardial infarction after percutaneous coronary intervention
por: Yu, Junjian, et al.
Publicado: (2023)

Mammalian target of rapamycin inhibitors for treatment in tuberous sclerosis
por: Kim, Won Seop
Publicado: (2011)

Therapeutic control of leishmaniasis by inhibitors of the mammalian target of rapamycin
por: Khadir, Fatemeh, et al.
Publicado: (2018)

New Developments in Mammalian Target of Rapamycin Inhibitors for the Treatment of Sarcoma
por: Agulnik, Mark
Publicado: (2012)

Retraction: Mammalian target of rapamycin inhibitors for treatment in tuberous sclerosis
por: Kim, Won Seop
Publicado: (2013)

Oedema, solid organ transplantation and mammalian target of rapamycin inhibitor/proliferation signal inhibitors (mTOR-I/PSIs)
por: Gharbi, Chems, et al.
Publicado: (2014)

Combining the mammalian target of rapamycin inhibitor, rapamycin, with resveratrol has a synergistic effect in multiple myeloma
por: Jin, Hong-Guang, et al.
Publicado: (2018)

Renal toxicity with mammalian target of rapamycin inhibitors: A meta-analysis of randomized clinical trials
por: Paluri, Ravi K., et al.
Publicado: (2019)

Suppression of Allograft Fibrosis by Regulation of Mammalian Target of Rapamycin-Related Protein Expression in Kidney-Transplanted Recipients Treated with Everolimus and Reduced Tacrolimus
por: Nishioka, Shun, et al.
Publicado: (2021)

Clinicopathological correlations in heart transplantation recipients complicated by death or re-transplantation
por: McDonald, Michelle M., et al.
Publicado: (2022)

Oral Preconditioning of Donors After Brain Death With Calcineurin Inhibitors vs. Inhibitors of Mammalian Target for Rapamycin in Pig Kidney Transplantation
por: Abbasi Dezfouli, Sepehr, et al.
Publicado: (2020)

Ku-0063794 is a specific inhibitor of the mammalian target of rapamycin (mTOR)
por: García-Martínez, Juan M., et al.
Publicado: (2009)

Hyperkalemia: Major but still understudied complication among heart transplant recipients
por: Singh, Jagmeet, et al.
Publicado: (2021)

Neurologic Complications in Heart Transplant Recipients Readmitted to the Intensive Care Unit
por: Şahintürk, Helin, et al.
Publicado: (2021)

Radiofrequency ablation-induced superior vena cava stenosis in a 5-year-old boy with congenital left atrial appendage deformity: a case report and literature review
por: Xiong, Jianxian, et al.
Publicado: (2023)

Mammalian target of rapamycin inhibition attenuates myocardial ischaemia–reperfusion injury in hypertrophic heart
por: Ma, Lei‐Lei, et al.
Publicado: (2018)

Rheb and mammalian target of rapamycin in mitochondrial homoeostasis
por: Groenewoud, Marlous J., et al.
Publicado: (2013)

Mammalian Target of Rapamycin Inhibitors Resistance Mechanisms in Clear Cell Renal Cell Carcinoma
por: Kornakiewicz, Anna, et al.
Publicado: (2013)

Surgical Site Infections Complicating the Use of Negative Pressure Wound Therapy in Renal Transplant Recipients
por: Lam, Susanna, et al.
Publicado: (2019)

462 Impact of Pre-transplant LVAD Therapy on Survival and Infectious Complications in Heart Transplant Recipients
por: Arif, Sana, et al.
Publicado: (2014)

Inhibition of mammalian target of rapamycin by rapamycin increases the radiosensitivity of esophageal carcinoma Eca109 cells
por: ZHANG, DEJUN, et al.
Publicado: (2014)

Infectious Complications in Lung Transplant Recipients
por: Trachuk, Polina, et al.
Publicado: (2020)

SIRT1 Negatively Regulates the Mammalian Target of Rapamycin
por: Ghosh, Hiyaa Singhee, et al.
Publicado: (2010)

Mammalian target of rapamycin signaling in diabetic cardiovascular disease
por: Chong, Zhao Zhong, et al.
Publicado: (2012)

Driving neural regeneration through the mammalian target of rapamycin
por: Maiese, Kenneth
Publicado: (2014)

Autism Spectrum Disorder and Mammalian Target of Rapamycin System
por: Posar, Annio, et al.
Publicado: (2020)

Crosstalk of the Caspase Family and Mammalian Target of Rapamycin Signaling
por: Yan, Junfang, et al.
Publicado: (2021)

Assessing the efficacy of mammalian target of rapamycin inhibitors by phosphorylation of p70S6K in CD4-positive cells of liver transplant patients
por: Wang, Jun-Yu, et al.
Publicado: (2019)

Rapamycin protects against aristolochic acid nephropathy in mice by potentiating mammalian target of rapamycin-mediated autophagy
por: Lin, Fan, et al.
Publicado: (2021)

Efficacy and safety of a mammalian target of rapamycin inhibitor in pediatric patients with tuberous sclerosis complex: A systematic review and meta-analysis
por: YANG, GUANG, et al.
Publicado: (2015)

Mammalian Tribbles Homologs at the Crossroads of Endoplasmic Reticulum Stress and Mammalian Target of Rapamycin Pathways
por: Cunard, Robyn
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_co8i1gdlioi5rvedabcsq1kpom